Literature DB >> 27006339

Initial development of patient-reported instrument assessing harm, efficacy, and misuse of long-term opioid therapy.

William C Becker1, David A Fiellin, Anne C Black, Carol T Kostovich, Robert D Kerns, Liana Fraenkel.   

Abstract

Guidelines on long-term opioid therapy recommend frequent reassessment of harm, efficacy, and misuse of these potentially harmful and sometimes ineffective medications. In primary care, there is a need for a brief, patient-reported instrument. This report details the initial steps in the development of such an instrument. An interdisciplinary team of clinician-scientists performed four discrete steps in this study: (1) conceptualization of the purpose and function of the instrument, (2) assembly of an item pool, (3) expert rating on which items were most important to include in the instrument, and (4) modification of expert-selected items based on a reading level check and cognitive interviews with patients. A diverse panel of 47 subject matter experts was presented with 69 items to rate on a 1-9 scale in terms of importance for inclusion in the instrument. The panel highly rated 37 items: 8 related to harm, 4 related to efficacy, and 25 related to misuse. These 37 items were then tested for patient comprehension and modified as needed. Next steps in development will include further item reduction, testing against a gold standard, and assessment of the instrument's effect on clinical outcomes.

Entities:  

Keywords:  chronic pain; efficacy; harm; instrument development; misuse; opioid analgesics; opioid therapy; pain management; patient reported; therapeutic monitoring

Mesh:

Substances:

Year:  2016        PMID: 27006339      PMCID: PMC4806533          DOI: 10.1682/JRRD.2014.11.0285

Source DB:  PubMed          Journal:  J Rehabil Res Dev        ISSN: 0748-7711


  26 in total

Review 1.  Core outcome measures for chronic pain clinical trials: IMMPACT recommendations.

Authors:  Robert H Dworkin; Dennis C Turk; John T Farrar; Jennifer A Haythornthwaite; Mark P Jensen; Nathaniel P Katz; Robert D Kerns; Gerold Stucki; Robert R Allen; Nicholas Bellamy; Daniel B Carr; Julie Chandler; Penney Cowan; Raymond Dionne; Bradley S Galer; Sharon Hertz; Alejandro R Jadad; Lynn D Kramer; Donald C Manning; Susan Martin; Cynthia G McCormick; Michael P McDermott; Patrick McGrath; Steve Quessy; Bob A Rappaport; Wendye Robbins; James P Robinson; Margaret Rothman; Mike A Royal; Lee Simon; Joseph W Stauffer; Wendy Stein; Jane Tollett; Joachim Wernicke; James Witter
Journal:  Pain       Date:  2005-01       Impact factor: 6.961

Review 2.  Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction.

Authors:  Bridget A Martell; Patrick G O'Connor; Robert D Kerns; William C Becker; Knashawn H Morales; Thomas R Kosten; David A Fiellin
Journal:  Ann Intern Med       Date:  2007-01-16       Impact factor: 25.391

3.  How do stakeholder groups vary in a Delphi technique about primary mental health care and what factors influence their ratings?

Authors:  S M Campbell; T Shield; A Rogers; L Gask
Journal:  Qual Saf Health Care       Date:  2004-12

4.  The Edmonton symptom assessment system--what do patients think?

Authors:  Sharon Watanabe; Cheryl Nekolaichuk; Crystal Beaumont; Asifa Mawani
Journal:  Support Care Cancer       Date:  2008-10-25       Impact factor: 3.603

5.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Authors:  Roger Chou; Gilbert J Fanciullo; Perry G Fine; Jeremy A Adler; Jane C Ballantyne; Pamela Davies; Marilee I Donovan; David A Fishbain; Kathy M Foley; Jeffrey Fudin; Aaron M Gilson; Alexander Kelter; Alexander Mauskop; Patrick G O'Connor; Steven D Passik; Gavril W Pasternak; Russell K Portenoy; Ben A Rich; Richard G Roberts; Knox H Todd; Christine Miaskowski
Journal:  J Pain       Date:  2009-02       Impact factor: 5.820

Review 6.  Research gaps on use of opioids for chronic noncancer pain: findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline.

Authors:  Roger Chou; Jane C Ballantyne; Gilbert J Fanciullo; Perry G Fine; Christine Miaskowski
Journal:  J Pain       Date:  2009-02       Impact factor: 5.820

7.  An open-label, dose escalation pilot study of the effect of clonazepam in burning mouth syndrome.

Authors:  M Grushka; J Epstein; A Mott
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1998-11

8.  The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years.

Authors:  David Cella; Susan Yount; Nan Rothrock; Richard Gershon; Karon Cook; Bryce Reeve; Deborah Ader; James F Fries; Bonnie Bruce; Mattias Rose
Journal:  Med Care       Date:  2007-05       Impact factor: 2.983

Review 9.  Opioid therapy for chronic pain in the United States: promises and perils.

Authors:  Mark D Sullivan; Catherine Q Howe
Journal:  Pain       Date:  2013-09-11       Impact factor: 6.961

Review 10.  Current concepts in validity and reliability for psychometric instruments: theory and application.

Authors:  David A Cook; Thomas J Beckman
Journal:  Am J Med       Date:  2006-02       Impact factor: 4.965

View more
  1 in total

1.  "Clues" That Patients May Be Willing to Consider Opioid Reductions.

Authors:  William C Becker
Journal:  J Gen Intern Med       Date:  2020-06       Impact factor: 5.128

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.